On ECHEMI

Beijing Huafeng United Technology Co., Ltd

Districts,Beijing,China
Favorite Supplier
 1590 people visit

Company Profile

It was established in 2005, specializing in the sales of laboratory instrument consumables and chemical reagents. It is a scientific and technological enterprise specializing in the intermediates of laboratory chemical materials. The company has strong new product development capabilities. , Specializing in the research and development of new compounds, and established extensive cooperation with Beijing University of Chemical Technology. In order to better adapt to the company’s development needs, the company’s shareholders additionally established Beijing Mysore Chemical Technology Co., Ltd. in 2009, which is responsible for import and export business. . Based on the abundant resources of universities in Beijing, the company keeps innovating, focusing on the development of new products and transforming them into products with technology. It has developed a number of high-tech products and has its own product characteristics in the increasingly competitive chemical industry.

VIEW MORE VIEW LESS

Product List

Product Name Synonyms CAS No. Grate/Content Operate

(1R)-8-Chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine hydrochloride hemihydrate

(R)-8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine hydrochloride hydrate;(1R)-8-Chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine hydrochloride hemihydrate;C11H14ClN.ClH.H2O;SCHEMBL173222;CHEMBL3527027;KS-00000LF4;2112AH;AKOS027338662;DS-12219;(1R)-8-Chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine hydrochloride hemihydrate
856681-05-5 Inquiry

(1R,2R)-(-)-1,2-CYCLOHEXANEDICARBOXYLIC ACID

46022-05-3 Inquiry

(1R,2R)-1,2-CYCLOHEXANEDIMETHANOL

Lurasidone INT 3;[(1R,2R)-2-(hydroxymethyl)cyclohexyl]methanol;(1R,2R)-1,2-CYCLOHEXANEDI;(1R,2R)-1,2-Cyclohexanedimethanol;(1R,2R)-1,2-CYCLOHEXANEDIMETHANOL;(1R,2R)-cyclohexane-1,2-diyldimethanol;(1R,2R)-1,2-Bis(hydroxymethyl)cyclohexane;1,2-CyclohexanediMethanol, (1R,2R)-
65376-05-8 Inquiry

(1R,2S)-rel-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide hydrochloride

Cyclopropanecarboxamide,2-(aminomethyl)-N,N-diethyl-1-phenyl-,hydrochloride (1:1),(1R,2S)-rel-;Cyclopropanecarboxamide,2-(aminomethyl)-N,N-diethyl-1-phenyl-,monohydrochloride,cis-(±)-;Cyclopropanecarboxamide,2-(aminomethyl)-N,N-diethyl-1-phenyl-,monohydrochloride,(1R,2S)-rel-;F 2207;Milnacipran hydrochloride;Cyclopropanecarboxamide,2-(aminomethyl)-N,N-diethyl-1-phenyl-,monohydrochloride,cis-;Ixel;Dalcipran;Toledomin;Savella;Tivanyl;Joncia;86181-08-0
101152-94-7 Inquiry

(1S)-1,5-Anhydro-1-C-[3-[(1-benzothiophen-2-yl)methyl]-4-fluorophenyl]-D-glucitol

D-Glucitol,1,5-anhydro-1-C-[3-(benzo[b]thien-2-ylmethyl)-4-fluorophenyl]-,(1S)-;(1S)-1,5-Anhydro-1-C-[3-(benzo[b]thien-2-ylmethyl)-4-fluorophenyl]-D-glucitol;Ipragliflozin;ASP 1941;Suglat;2169850-09-1
761423-87-4 Inquiry

(1S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline

Isoquinoline,1,2,3,4-tetrahydro-1-phenyl-,(1S)-;Isoquinoline,1,2,3,4-tetrahydro-1-phenyl-,(S)-;(1S)-1,2,3,4-Tetrahydro-1-phenylisoquinoline;(S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline;(1S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline;(+)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline;(S)-(+)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline;(1S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline;(-)-(S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline;(S)-1,2,3,4-Tetrahydro-1-phenylisoquinoline
118864-75-8 Inquiry

(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-dodecahydro-9,11-dihydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-7,11-methano-5H-cyclodeca[3,4]benz[1,2-b]oxet-5-one

7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxet-5-one,12b-(acetyloxy)-12-(benzoyloxy)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-dodecahydro-9,11-dihydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-,(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-;7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxet-5-one,12b-(acetyloxy)-12-(benzoyloxy)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-dodecahydro-9,11-dihydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-,[2aR-(2aα,4β,4aβ,6β,9α,11α,12α,12aα,12bα)]-;(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-dodecahydro-9,11-dihydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-7,11-methano-5H-cyclodeca[3,4]benz[1,2-b]oxet-5-one;4α-Acetoxy-2α-benzoyloxy-5β,20-epoxy-1β,13α-dihydroxy-7β,10β-dimethoxy-9-oxo-11-taxene;10-Deacetyl-7,10-dimethylbaccatin III;7β,10β-Dimethoxy-10-deacetylbaccatin III;7,10-Dimethoxy-10-deacetylbaccatin III;10-Deacetylbaccatin III 7,10-dimethyl ether
183133-94-0 Inquiry

(2R,3S/2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

4-Pyrimidineethanol,α-(2,4-difluorophenyl)-5-fluoro-β-methyl-α-(1H-1,2,4-triazol-1-ylmethyl)-;α-(2,4-Difluorophenyl)-5-fluoro-β-methyl-α-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol;2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol;2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol;2-(2,4-Difluoro-phenyl)-3-(5-fluoro-pyrimidin-4-yl)-1-[1,2,4]triazol-1-yl-butan-2-ol
182230-43-9 Inquiry

(3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione

14805-29-9 Inquiry

(3R,4S)-3-Hydroxy-4-phenyl-2-azetidinone

CIS-3-HYDROXY-4-PHENYL-2-AZETIDINONE;(3R,4S)-3-Hydroxy-4-phenylazetidin-2-one;(3R,4S)-;(3R,4S)-3-HYDROXY-4-PHENYL-2-AZETIDINONE;(3r-cis)-3-hydroxy-4-phenyl-2-azetidinone;3-hydroxy-4-phenyl-2-azetidinone;Cabazitaxel Impurity 56;4S)-3-Hydroxy-4-phenyl-2-azetidinone
132127-34-5 Inquiry

(4S)-(2,2-dimethyl-1,3-dioxolan-4-yl)-3-(4- hydroxybenzene) propanoic acid,methyl ester (Landiolol)

(4S)-(2,2-dimethyl-1,3-dioxolan-4-yl)-3-(4- hydroxybenzene) propanoic acid,methyl ester (Landiolol);((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)methyl 3-(4-hydroxyphenyl)propanoate;Benzenepropanoicacid,4-hydroxy-,[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methylester;4-Hydroxybenzenepropanoic acid [(4S)-2,2-diMethyl-1,3-dioxolan-4-yl]Methyl ester;4S)-(2,2-diMethyl-1,3-dioxolan-4-yl)-3-(4-hydroxybenzene) propanoicacid,Methyl ester;Landiolol HClPI-1;4-Hydroxybenzenepropanoic acid [(4S)-2,2-dimethyl-1,3
144256-11-1 Inquiry

(R)-(-)-3-Pyrrolidinol hydrochloride

3-Pyrrolidinol,hydrochloride (1:1),(3R)-;3-Pyrrolidinol,hydrochloride,(R)-;3-Pyrrolidinol,hydrochloride,(3R)-;(R)-(-)-3-Pyrrolidinol hydrochloride;(R)-(-)-3-Hydroxypyrrolidine hydrochloride;(3R)-3-Hydroxypyrrolidine hydrochloride;(3R)-3-Pyrrolidinol hydrochloride;(R)-3-Hydroxypyrrolidine hydrochloride;(R)-3-Pyrrolidinol hydrochloride;3-(R)-Hydroxypyrrolidine hydrochloride;(R)-Pyrrolidin-3-ol hydrochloride;(3R)-Pyrrolidin-3-ol hydrochloride;(R)-(-)-3-Hydroxypyrrolidine hydrochloride;(R)-3-Hydroxypyrrolidine hydrochloride
104706-47-0 Inquiry

(R)-(-)-3-Quinuclidinol

1-Azabicyclo[2.2.2]octan-3-ol,(3R)-;3-Quinuclidinol,(-)-;1-Azabicyclo[2.2.2]octan-3-ol,(R)-;(3R)-1-Azabicyclo[2.2.2]octan-3-ol;l-3-Quinuclidinol;(R)-(-)-3-Quinuclidinol;(R)-3-Quinuclidinol;(R)-1-Azabicyclo[2.2.2]octan-3-ol;(-)-3-Quinuclidinol;(3R)-Quinuclidin-3-ol;(3R)-3-Quinuclidinol;(R)-3-Hydroxyquinuclidine;(R)-3-Quinuclidol;(R)-(-)-1-Azabicyclo[2.2.2]octan-3-ol;R-Quinuclidin-3-ol;(-)-(R)-3-Quinuclidinol;(3R)-Quinuclidinol;(3R)-1-Azabicyclo[2.2.2]octan-3-ol
25333-42-0 Inquiry

(R)-1H-3-BENZAZEPINE,8-CHLORO-2,3,4,5-TETRAHYDRO-1-METHYL-,HYDROCHLORIDE

1H-3-Benzazepine,8-chloro-2,3,4,5-tetrahydro-1-methyl-,hydrochloride (1:1),(1R)-;1H-3-Benzazepine,8-chloro-2,3,4,5-tetrahydro-1-methyl-,hydrochloride,(1R)-;(R)-8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride;Lorcaserin hydrochloride;APD 356;(R)-8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine hydrochloride;(R)-Lorcaserin hydrochloride
846589-98-8 Inquiry

(R)-3-Quinuclidinol hydrochloride

3-R-QUINUCLIDINOL HYDROCHLORIDE;(R)-3-QUINUCLIDINOL HCL;(R)-(-)-3-QUINUCLIDINOL HYDROCHLORIDE;(R)-3-QUINUCLIDINOL HYDROCHLORIDE;(R)-3-HYDROXYQUINUCLIDINE HYDROCHLORIDE;R(-)-3-HYDROXYQUINUCLIDINE HYDROCHLORIDE;(R)-1-AZABICYCLO[2.2.2]OCTAN-3-OL HYDROCHLORIDE;(R)-(-)-3-Hydroxyguinuclidine hydrochloride
42437-96-7 Inquiry

(R*,R*)-N-[2-Hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide fumarate dihydrate

(r*,r*)-n-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide fumarate dihydrate;Formoterol fumarate dihydrate;Formamide, N-(2-hydroxy-5-((1R)-1-hydroxy-2-(((1R)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)-, rel-, (2E)-2-butenedioate (2:1) (salt), dihydrate;Unii-W34shf8J2k;(±)-(R,R)-N-[2-Hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamidehemifumarate;Formoterol fumarate dihydrate ,98.5%;Formoterol Fumarate (100 mg);forMaMide fuMarate dihydrate
183814-30-4 Inquiry

(S)-(+)-Glycidyl nosylate

Benzenesulfonic acid,3-nitro-,(2S)-2-oxiranylmethyl ester;Benzenesulfonic acid,3-nitro-,oxiranylmethyl ester,(S)-;Benzenesulfonic acid,3-nitro-,(2S)-oxiranylmethyl ester;(S)-Glycidyl 3-nitrobenzenesulfonate;(S)-2,3-Epoxypropyl 3-nitrobenzenesulfonate;(S)-Glycidyl m-nitrobenzenesulfonate;(S)-(+)-Gycidyl 3-nitrobenzenesulfonate;(2S)-(+)-Glycidyl 3-nitrobenzenesulfonate;(S)-(+)-3-Nitrobenzenesulfonic acid oxiranylmethyl ester;(2S)-Glycidyl 3-nitrobenzenesulfonate;(S)-(+)-Glycidyl 3-nitrobenzenesulfonate;(2S)-(+)-Glycidyl 3-nitrobenzenesulfonate;(2S)-Oxiranylmethyl 3-nitrobenzenesulfonate;((2S)-Oxiran-2-yl)methyl 3-nitrobenzenesulfonate;(S)-(2,3-Epoxypropan-1-yl) 3-nitrobenzenesulfonate;(S)-Oxiran-2-ylmethyl 3-nitrobenzenesulfonate;3-Nitrobenzenesulfonic acid (S)-oxiran-2-ylmethyl ester;3-Nitrobenzenesulfonic acid (2S)-oxiran-2-ylmethyl ester;(S)-(+)-3-Nitrobenzenesulfonic acid glycidyl ester;3-Nitrobenzenesulfonic acid (S)-glycidyl ester;(S)-3-Nitrobenzenesulfonic acid oxiranylmethyl ester;[(2S)-Oxiran-2-yl]methyl 3-nitrobenzenesulfonate;(S)-Oxiran-2-yl methyl 3-nitrobenzenesulfonate;203991-21-3
115314-14-2 Inquiry

(S)-(+)-GLYCIDYL PHTHALIMIDE

1H-Isoindole-1,3(2H)-dione,2-[(2S)-2-oxiranylmethyl]-;1H-Isoindole-1,3(2H)-dione,2-(oxiranylmethyl)-,(S)-;1H-Isoindole-1,3(2H)-dione,2-[(2S)-oxiranylmethyl]-;2-[(2S)-2-Oxiranylmethyl]-1H-isoindole-1,3(2H)-dione;N-((2S)-Oxiran-2-ylmethyl)phthalimide;2-[(S)-2-Oxiranylmethyl]-1H-isoindol-1,3(2H)-dione;N-(S)-Glycidylphthalimide;(S)-N-(2,3-Epoxypropan-1-yl)phthalimide;(S)-2-[(Oxiranyl)methyl]isoindole-1,3-dione;(S)-N-(2,3-Epoxypropyl)phthalimide;(S)-2-(Oxiran-2-ylmethyl)-1H-isoindole-1,3(2H)-dione;N-[(+)-Glycidyl]phthalimide;N-[(S)-(+)-Glycidyl]phthalimide;(S)-Glycidyl Phthalimide;(S)-N-Giycidylphthalimide;(S)-2-(Oxiran-2-ylmethyl)isoindoline-1,3-dione;(S)-N-Glycidylphthalimide;2-[[(2S)-Oxiran-2-yl]methyl]isoindole-1,3-dione
161596-47-0 Inquiry

(S)-(-)-1,2-Diaminopropane dihydrochloride

1,2-Propanediamine,hydrochloride (1:2),(2S)-;1,2-Propanediamine,dihydrochloride,L-;1,2-Propanediamine,dihydrochloride,(S)-;1,2-Propanediamine,dihydrochloride,(2S)-;(S)-(-)-1,2-Propanediamine dihydrochloride;(S)-1,2-Diaminopropane dihydrochloride;(S)-(-)-1,2-Diaminopropane dihydrochloride;(S)-Propane-1,2-diamine dihydrochloride
19777-66-3 Inquiry

(S)-1,2,3,4-tetrahydro-5-methoxy-N-propyl-2-Naphthalenamine(Rotigotine)

(S)-1,2,3,4-tetrahydro-5-methoxy-N-propyl-2-Naphthalenamine(Rotigotine);(S)-1,2,3,4-Tetrahydro-5-methoxy-N-propyl-2-naphthalenamine;Rotigotine InterMediate;(S)-5-Methoxy-N-propyl-1,2,3,4-tetrahydronaphthalen-2-aMine;2-NaphthalenaMine, 1,2,3,4-tetrahydro-5-Methoxy-N-propyl-, (S)-
101403-24-1 Inquiry

CONTACT INFORMATION

Send an inquiry

Product Name:
Quantity:
Shipment Term:

United States

  • China
  • Albania
  • Algeria
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Brazil
  • Brunei
  • Bulgaria
  • Burkina-faso
  • Burundi
  • Cameroon
  • Canada
  • Cape Verde
  • Cayman Islands
  • Central African
  • Chad
  • Chile
  • Colombia
  • Comoros
  • Cook Is.
  • Costa Rica
  • Croatia
  • Curacao
  • Cyprus
  • Czech
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Honduras
  • Hongkong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Ivory Coast
  • Jamaica
  • Japan
  • Jordan
  • Kampuchea (Cambodia )
  • Kazakstan
  • Kenya
  • Kiribati
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macao, China
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Island
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Norfolk Island
  • North Macedonia
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Cuinea
  • Paraguay
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Republic of the Congo
  • Reunion Island
  • Romania
  • Russia
  • Rwanda
  • Saint Kitts and Nevis
  • Saint Martin
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Slovakia
  • Slovenia
  • Solomon Is
  • Somali
  • South Africa
  • South Korea
  • South Sudan
  • Spain
  • Sri Lanka
  • St.Lucia
  • Suriname
  • Swaziland
  • Sweden
  • Switzerland
  • Taiwan, China
  • Tajikstan
  • Tanzania
  • Thailand
  • The British Virgin Islands
  • The Dominican Republic
  • The Islamic Republic of Mauritania
  • The Islands of st pierre and miquelon
  • The Turks and Caicos Islands
  • Timor-Leste
  • Togo
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Tuvalu
  • Uganda
  • United Arab Emirates
  • United Kingdom
  • United States
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Vatican
  • Vietnam
  • Wallis et Futuna
  • Western Sahara
  • Yemen
  • Zaire
  • Zambia
  • Zimbabwe
  • Afghanistan
  • Belarus
  • Cuba
  • Iran
  • Iraq
  • Libya
  • North Korea
  • Sudan
  • Syria
  • Ukraine
  • Venezuela
Message:
0/2000
Accept quotations from other qualified suppliers on ECHEMI.com

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.